1. Home
  2. SLN vs IE Comparison

SLN vs IE Comparison

Compare SLN & IE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLN
  • IE
  • Stock Information
  • Founded
  • SLN 1994
  • IE 2020
  • Country
  • SLN United Kingdom
  • IE United States
  • Employees
  • SLN N/A
  • IE N/A
  • Industry
  • SLN Biotechnology: Pharmaceutical Preparations
  • IE Metal Mining
  • Sector
  • SLN Health Care
  • IE Basic Materials
  • Exchange
  • SLN Nasdaq
  • IE Nasdaq
  • Market Cap
  • SLN 919.6M
  • IE 841.6M
  • IPO Year
  • SLN N/A
  • IE 2022
  • Fundamental
  • Price
  • SLN $18.50
  • IE $9.89
  • Analyst Decision
  • SLN Strong Buy
  • IE Buy
  • Analyst Count
  • SLN 4
  • IE 2
  • Target Price
  • SLN $61.50
  • IE $16.00
  • AVG Volume (30 Days)
  • SLN 179.3K
  • IE 716.4K
  • Earning Date
  • SLN 11-12-2024
  • IE 11-06-2024
  • Dividend Yield
  • SLN N/A
  • IE N/A
  • EPS Growth
  • SLN N/A
  • IE N/A
  • EPS
  • SLN N/A
  • IE N/A
  • Revenue
  • SLN $22,623,125.00
  • IE $2,808,000.00
  • Revenue This Year
  • SLN N/A
  • IE N/A
  • Revenue Next Year
  • SLN $104.98
  • IE $39.06
  • P/E Ratio
  • SLN N/A
  • IE N/A
  • Revenue Growth
  • SLN N/A
  • IE N/A
  • 52 Week Low
  • SLN $6.51
  • IE $6.31
  • 52 Week High
  • SLN $27.72
  • IE $12.98
  • Technical
  • Relative Strength Index (RSI)
  • SLN 48.92
  • IE 68.80
  • Support Level
  • SLN $18.20
  • IE $8.31
  • Resistance Level
  • SLN $19.36
  • IE $9.19
  • Average True Range (ATR)
  • SLN 0.88
  • IE 0.43
  • MACD
  • SLN -0.04
  • IE 0.11
  • Stochastic Oscillator
  • SLN 35.50
  • IE 80.61

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid. its pipeline products are; SLN360 therapy designed to temporarily block a specific gene's message that would otherwise trigger an unwanted effect. By silencing the LPA gene, the levels of Lp(a) are lowered, which in turn is expected to lower the risks of heart diseases, heart attacks, and strokes, and SLN124 therapy aims to temporarily silence TMPRSS6, a gene that prevents the liver from producing a particular hormone that controls iron levels in the body hepcidin. As hepcidin increases, iron levels in the blood are expected to decrease, which may increase the production of healthy red blood cells, thereby reducing anemia.

About IE Ivanhoe Electric Inc.

Ivanhoe Electric Inc is a United States-based minerals exploration and development company with a focus on developing mines from mineral deposits located in the United States. The company has three reportable segments; Critical metals segment is focused on mineral project exploration and development with a focus on identifying and developing mineral projects, and ultimately mines, associated with the metals necessary for electrification, The data processing segment provides data analytics, geophysical modeling, and artificial intelligence services for the mineral, oil & gas and water exploration industries, and The energy storage segment develops, manufactures and installs vanadium flow batteries for grid-scale energy storage. It derives a majority of its revenue from Canada.

Share on Social Networks: